Finland | BCH-LAW-FI-105704 | Biosafety Law, Regulation, Guidelines and Agreements

Loading...

This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.

Click here to view the deleted record

This document has been updated. This is not the latest published version. Click here to view the latest version of the record.

Comparing version with latest version 3

Biosafety Law, Regulation, Guidelines and Agreements (LAW)

BCH-LAW-FI-105704-3 | PDF | Print |

| Close

published: 01 Aug 2014 last updated: 25 Feb 2026

Amendment

Is this an amendment to a law, regulation, guideline or agreement already published on the BCH?

General Information

Country submitting a law, regulation, guideline or agreement

Finland

Title

Government Decree on Chargeable Performances under the Gene Technology Act (1195/2025)

Legislative details

Type of Law / Regulation

Regulation or administrative measure

Area of jurisdiction

National / Federal

Subject areas

Contained use
Intentional introduction into the environment (AIA)
Other
- fees collected on the applications, notifications and inspections

Types of organisms addressed

All types of organisms

Brief description of the document including objective and scope

This decree lays out the fees collected of chargeable performances under the Gene Technology Act (notifications, applications, inspections and sampling)

Date of entry into force

01 Jan 2026

Document details

Document text

Relationship with other laws/regulations

Record(s) containing the related measure(s)

BCH-LAW-FI-11255-4 Biosafety Law, Regulation, Guidelines and Agreements Gene Technology Act

Contained use, Handling, transport, packaging and identification, Intentional introduction into the environment (AIA), LMOs for direct use as feed, LMOs for direct use as food, LMOs for processing, Pharmaceuticals, Public awareness and participation, Transboundary movement (import/export), Transit

Description of the relationship between the measures

The Decree is about the fees regarding LMO notifications, applications and inspections as stipulated in the Gene Technology Act (377/1996).

Regulatory contact information Competent National Authority(ies) and/or Supplementary Protocol Competent Authority(ies)

- Competent National Authority: | BCH-CNA-FI-5496-7

Competent National Authority:

Board for Gene Technology ()

POB 33
Government,
FIN-00023, Finland
Phone: +358 295 16001,

Fax:

Email: gtlk@gov.fi,

Website: http://www.geenitekniikanlautakunta.fi,

BCH-CNA-FI-5496-7

BCH-LAW-FI-105704-3 Report

This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.

This document has been updated. This is not the latest published version. Click here to view the latest version of the record.

Comparing version with latest version 3

Quick links

Need help?

THE CONVENTION ON BIOLOGICAL DIVERSITY

Quick Links

Topics

Information

A part of

This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.

This document has been updated. This is not the latest published version. Click here to view the latest version of the record.

Comparing version with latest version 3 Close comparison

Quick links

Need help?

THE CONVENTION ON BIOLOGICAL DIVERSITY

Quick Links

Topics

Information

A part of

Comparing version with latest version 3